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Research
AbstrACt
Objective To assess risk of bias and to investigate 
methodological issues concerning the design, conduct 
and analysis of randomised controlled trials (RCTs) testing 
acupuncture for knee osteoarthritis (KOA).
Methods PubMed, EMBASE, Cochrane Central 
Register of Controlled Trials and four major Chinese 
databases were searched for RCTs that investigated 
the effect of acupuncture for KOA. The Cochrane tool 
was used to examine the risk of bias of eligible RCTs. 
Their methodological details were examined using a 
standardised and pilot-tested questionnaire of 48 items, 
together with the association between four predefined 
factors and important methodological quality indicators.
results A total of 248 RCTs were eligible, of which 
39 (15.7%) used computer-generated randomisation 
sequence. Of the 31 (12.5%) trials that stated the 
allocation concealment, only one used central 
randomisation. Twenty-five (10.1%) trials mentioned 
that their acupuncture procedures were standardised, 
but only 18 (7.3%) specified how the standardisation 
was achieved. The great majority of trials (n=233, 94%) 
stated that blinding was in place, but 204 (87.6%) did not 
clarify who was blinded. Only 27 (10.9%) trials specified 
the primary outcome, for which 7 used intention-to-treat 
analysis. Only 17 (6.9%) trials included details on sample 
size calculation; none preplanned an interim analysis 
and associated stopping rule. In total, 46 (18.5%) trials 
explicitly stated that loss to follow-up occurred, but only 6 
(2.4%) provided some information to deal with the issue. 
No trials prespecified, conducted or reported any subgroup 
or adjusted analysis for the primary outcome.
Conclusion The overall risk of bias was high 
among published RCTs testing acupuncture for KOA. 
Methodological limitations were present in many important 
aspects of design, conduct and analyses. These findings 
inform the development of evidence-based methodological 
guidance for future trials assessing the effect of 
acupuncture for KOA.
bACkgrOund 
Knee osteoarthritis (KOA) is a major health 
concern worldwide and its disease burden 
continues to increase due to population 
ageing.1 2 Standard treatments for KOA, 
such as non-steroid anti-inflammatory drugs, 
glucosamine and intra-articular injections, 
are often of limited effects.3–6 Acupuncture 
has received increasing attention,7 8 and is 
becoming popular in many Western coun-
tries.2 Approximately one million American 
patients with musculoskeletal disorders are 
now treated with acupuncture annually.9 
A number of randomised controlled trials 
(RCTs) have been conducted to test the 
effects of acupuncture on KOA. However, 
the evidence so far is weak, and the majority 
of trials had low methodological quality.10–12 
Due to the lack of compelling evidence, 
acupuncture has not been recommended as a 
treatment option for KOA in the most recent 
clinical practice guidelines.2 13–15
Although there is strong consensus that 
efforts should be made to improve the quality 
of such trials, no established methodological 
guidance is available to inform researchers 
about how to rigorously design, conduct and 
strengths and limitations of this study
 ► The literature search was comprehensive, and 
detailed inclusion and exclusion criteria were 
developed to ensure transparency and reproducibility 
in the judgements.
 ► A standardised and pilot-tested questionnaire was 
used to systematically assess the methodological 
issues concerning the design, conduct and analysis 
of randomised controlled trials testing acupuncture 
for knee osteoarthritis.
 ► The insufficient reporting of methodological details 
among those published trials limited our assessment 
of the methodological quality and identification of 
specific methodological gaps.
 ► In addition, this study did not examine the 
specification of patient population in those trials, 
and the findings may not be applicable to other 
acupuncture trials.
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analyse a trial of acupuncture for KOA. Unlike classical 
drug trials, RCTs of acupuncture have many specific 
features. For instance, acupuncture, as a typical complex 
intervention, is often expertise/preference-based, varies 
in practice and contains multiple components. Patient 
characteristics and study settings are also complex. 
Blinding may be challenging. Thus, there are special 
issues concerning the design, conduct and analysis of 
RCTs of acupuncture for KOA. Our ultimate goal is to 
develop a methodological guidance for rigorous design, 
conduct and analysis of acupuncture RCTs for KOA. 
Understanding methodological characteristics of previ-
ously published RCTs testing acupuncture for KOA would 
be the first and critical step.
Therefore, we conducted a cross-sectional study of 
published RCTs specifically testing acupuncture for KOA, 
so as to examine their methodological details. The find-
ings provide critical information and valuable insights to 
identify important methodological gaps and support the 
development of methodological guidance.
MethOds
eligibility criteria
An eligible study had to meet all of the following inclu-
sion criteria: (1) a two-arm RCT, regardless of study type 
(superiority, non-inferiority or equivalence); (2) enrolled 
patients diagnosed with KOA; (3) tested the effect of 
acupuncture in an uncounfunded manner. That is, 
acupuncture may be used alone or in combination with 
other treatments, as long as the effects of acupuncture 
can be parcelled out. The types of acupuncture may 
include electro-acupuncture, filiform needle, fire needle, 
silver needle, dry needle, laser acupuncture, ear acupunc-
ture and scalp acupuncture; (4) compared with another 
type of acupuncture, pharmacological intervention, 
placebo acupuncture, sham acupuncture, waiting list or 
physical treatments (eg, exercises and weight loss); and 
(5) reported findings in the full text of the paper.
We excluded study protocol from our study. Trials 
reported in research letters or conference abstracts were 
also excluded.
Literature search
We searched PubMed, EMBASE, Cochrane Central 
Register of Controlled Trials as well as four Chinese 
databases, namely Chinese Biomedical Database, China 
National Knowledge Infrastructure, Wanfang and China 
Science and Technology Journal Database (VIP). The 
search was conducted from inception to February 2017 
and for articles published in either English or Chinese. 
A combination of keywords and Medical Subject Head-
ings related to KOA, acupuncture and RCT was used after 
consulting an experienced librarian (online supplemen-
tary appendix 1). We also manually screened reference 
lists of eligible papers for articles which were not identi-
fied by the computerised search.
study process
Using standardised and pilot-tested forms, two authors 
(PLJ and JLL) screened the titles and abstracts inde-
pendently and in duplicate for potential eligibility. They 
subsequently read the full texts to determine final eligi-
bility. Then, from the eligible RCTs, two other authors 
(PLJ and XZ) assessed their risk of bias and collected 
methodological details on design, conduct and analysis 
using a study-specific questionnaire comprising 48 items 
(see the ‘Study questionnaire’ section below). A third 
reviewer (XS) was involved as the adjudicator in case of 
discrepancy throughout the process.
risk of bias assessment
We assessed the risk of bias of included RCTs using the 
Cochrane Risk of Bias tool. This tool contains seven 
items: (1) randomisation sequence generation; (2) allo-
cation concealment; (3) blinding of participants and 
personnel; (4) blinding of outcome assessors; (5) incom-
plete outcome data; (6) selective reporting; and (7) other 
sources of bias. Each item was assigned one of three 
responses: ‘low risk of bias, high risk of bias or unclear 
risk of bias’ according to the Cochrane handbook.
study questionnaire
In order to fully examine the methodological details of 
eligible RCTs, the research team, consisting of clinical 
trial experts, statisticians and acupuncturists, developed 
a study-specific questionnaire.
In developing the questionnaire, we first reviewed 
existing tools for assessing methodological quality 
and reporting (eg, Cochrane Risk of Bias Tool and 
CONSORT), and drafted a list of items. Based on those 
items, the research team, through brainstorming, added 
other potentially useful items. Afterwards, the research 
team undertook six group discussions to ascertain rele-
vancy of each questionnaire item and clarify its definition. 
Items that only addressed issues of reporting were deleted 
due to out of the study scope. The resulting questionnaire 
was pilot-tested using 10 studies randomly selected from 
the eligible articles. Thereafter, the items were revised 
based on the pilot test results.
The final version of the study questionnaire (online 
supplementary appendix 2) consisted of 48 items 
covering the following aspects: general information (eg, 
publication year, scope of journal and funding sources), 
study design and conduct (eg, randomisation, allo-
cation concealment, standardisation of acupuncture 
procedures, blinding and sample size calculation) and 
data analysis (methods for dealing with loss to follow-up, 
subgroup analysis and adjustment for confounders).
statistical analysis
We qualitatively summarised the general characteristics 
about the design, conduct and data analysis of included 
studies. Number and percentage were used for multino-
mial or dichotomous outcomes, whereas median and IQR 
were calculated for continuous variables.
 o
n
 26 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019847 on 6 March 2018. Downloaded from 
3Jia P, et al. BMJ Open 2018;8:e019847. doi:10.1136/bmjopen-2017-019847
Open Access
In order to examine the factors associated with 
major methodological quality indicators, we conducted 
four separate multivariable regression analyses for 
the following: adequate generation of randomisation 
sequence (yes vs no or unclear), allocation conceal-
ment (yes vs no or unclear), blinding of participants 
and personnel (yes vs no or unclear) and blinding of 
outcome assessors (yes vs no or unclear). For each of 
the regression analyses, we included four prespeci-
fied factors, namely, language (English vs Chinese), 
multiple centre study (yes vs no or unclear), funding 
support (yes vs no or unclear) and sample size (catego-
rised according to the median).
resuLts
Our search resulted in 4527 reports, of which 557 were 
potentially eligible after title and abstract screening. On 
reviewing their full texts, 248 RCTs were finally included 
(figure 1). No additional RCTs were identified through 
screening of their reference lists.
general characteristics of included trials
The 248 RCTs (219 in Chinese and 29 in English) were 
published between 1992 and 2016. Table 1 summarises 
general characteristics of the included trials. The 
majority were single-centre trials (92.7%) published in a 
non-acupuncture related journal (76.6%). The median 
sample size was only 76 (range 20–632), and the median 
duration of follow-up was 4 weeks (range 1–48 weeks). 
Only one-quarter of the included trials reported sources 
of funding and all of them were funded by non-profit 
funding agencies. The median number of authors was 
3 (range 1–13).
risk of bias assessment of included trials
We found that almost half of the 248 trials were at low risk of 
bias for randomisation sequence generation (119, 48.0%) 
and incomplete outcome data (105, 42.3%). But only a 
small proportion of trials were at low risk of bias for alloca-
tion concealment (31, 12.5%), blinding of participants and 
personnel (15, 12.5%), blinding of outcome assessors (15, 
12.5%), selective reporting (9, 3.6%) and other sources of 
bias (7, 2.8%) (figure 2, online supplementary appendix 3). 
In general, the trials had a high risk of bias.
Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart for search and selection 
processes.
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Methodological details of included trials
Randomisation and allocation concealment
Of those 248 RCTs, 99 (39.9%) did not provide details 
on randomisation, and a large proportion (217, 87.5%) 
failed to specify the method for allocation concealment 
(table 2). Among those which provided details on rando-
misation (149, 60.1%), only 39 (26.2%) used a comput-
er-generated randomisation sequence (the preferred 
approach), 70 (47.0%) used a random number table, 
whereas others (40, 26.8%) adopted inadequate methods 
(eg, coin tossing, visit order) to generate the randomi-
sation sequence. Very few trials used blocked randomi-
sation (15, 6.0%) and stratification at randomisation 
(9, 3.6%).
Of the 31 trials (12.5%) that provided details about 
allocation concealment, only 1 (3.2%) reported central 
randomisation, whereas 30 trials (96.8%) used sequen-
tially numbered, opaque or sealed envelope methods. 
No details were available from other trials (217, 87.5%). 
Given their applied methods of generation, we judged 
that most of trials were unlikely to conceal treatment allo-
cation (see table 2).
Intervention and blinding
All 248 trials described interventions for each group 
(table 3). Types of acupuncture used in the interven-
tions group were filiform/ordinary needle (107, 43.1%), 
electro-acupuncture (98, 39.5%), fire needle (14, 5.7%), 
Table 1 General characteristics of included trials
Features of included RCTs
Total
(n=248,%)
Chinese
(n=219,%)
English
(n=29,%)
No. of authors (median (IQR)) 3 (2–5) 5 (4–7.5) 3 (1–4)
Sample size (median (IQR)) 76 (60–100) 80 (60–105) 60 (40–90.5)
  ≤76* 126 (50.8) 105 (47.9) 21 (72.4)
  >76 122 (49.2) 114 (52.1) 8 (27.6)
Single versus multicentre study
  Single centre 230 (92.7) 202 (92.2) 28 (96.6)
  Multicentre 18 (7.3) 17 (7.8) 1 (3.4)
Length of follow-up
  ≤4 weeks 162 (65.3) 153 (69.9) 9 (31.0)
  >4 weeks 82 (33.1) 64 (29.2) 18 (62.1)
  Unclear 4 (1.60) 2 (0.9) 2 (6.9)
Scope of journals
  Acupuncture-related 58 (23.4) 48 (21.9) 10 (34.5)
  Others (non-acupuncture) 190 (76.6) 171 (78.1) 19 (65.5)
Sources of funding
  Non-profit funding agencies 62 (25.0) 46 (21.0) 16 (55.2)
  Unclear 186 (75.0) 173 (79.0) 13 (44.8)
*Median.
RCT, randomised controlled trial.
Figure 2 Risk of bias assessment of randomised controlled trials of acupuncture for knee osteoarthritis (n=248).
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laser acupuncture (4, 1.6%) and non-conventional 
acupuncture (20, 8.1%), such as silver, Fu’s subcuta-
neous, blade and longitudinal needle. For the control 
group, the majority (184, 74.2%) administered a single 
intervention: acupuncture and moxibustion (51, 20.6%), 
pharmacological intervention (45, 18.1%), needle-knife 
(29, 11.7%), physical treatments (22, 8.9%), acupuncture 
(21, 8.5%), sham acupuncture (8, 3.2%), placebo acupunc-
ture (5, 2.0%), moxibustion (2, 0.8%) and waiting list (1, 
0.4%). Multiple interventions, such as pharmacological 
intervention in conjunction with acupuncture/physical 
treatments, were used in the remaining trials (64, 25.8%).
Standardisation of acupuncture procedures was 
poor across trials. Only 25 (10%) trials stated that 
acupuncture procedure was standardised, and only 18 
(7.3%) explicitly specified that the standardisation was 
conducted according to manual, specific guidelines or 
a standardised protocol. A small proportion of the trials 
(18, 7.3%) clearly stated that acupuncture was performed 
by acupuncturists, physicians and/or physiotherapists.
The great majority of trials (233, 94%) stated that 
blinding was in place, but most of them (204, 87.6%) 
did not clarify who was blinded. The blinding of patients, 
acupuncturists, outcome assessors or data analysts was 
mentioned in <10% of the RCTs. Only 12 trials (4.8%) 
stated that blinding was achieved by sham procedures, 
such as placebo acupuncture or sham acupuncture 
(table 3).
Sample size calculation
Only a small number of trials (17, 6.9%) included details 
regarding the sample size calculation (table 4). Among 
those 17 trials, 10 performed the calculation based on a 
defined primary outcome, 9 defined the α level, 12 gave 
the β value, 9 took into account the potential loss to 
follow-up and 11 used data from a pilot/previous study. 
None of the trials preplanned an interim analysis and 
associated stopping rule.
Primary outcome and data analysis
Only 27 (10.9%) RCTs specified a primary outcome of 
interest (eg, pain, function and quality of life, table 5). 
Among them, six mentioned the statistical analytic 
method, and seven reported intention-to-treat analysis for 
the primary outcome.
In total, 145 trials (58.5%) provided information 
regarding loss to follow-up, and 46 (31.7%) trials explic-
itly stated that loss to follow-up occurred. Among these 46 
RCTs, 37 (80.4%) trials reported loss to follow-up separately 
for each arm, but only one compared baseline character-
istics of loss to follow-up patients between treatment and 
control groups. Only six trials (13.1%) provided some infor-
mation to deal with the problem. However, they did not 
specify the exact analytical methods for dealing with loss 
to follow-up in the primary outcome. Furthermore, none 
of trials prespecified, conducted or reported any subgroup 
analysis or adjustment for confounding variables (table 5).
Table 2 Randomisation and allocation concealment of included trials
Items
Total
(n=248,%)
English
(n=29,%)
Chinese
(n=219,%)
Methods of randomisation sequence generated
Reported 149 (60.1) 17 (58.6) 132 (60.3)
  A random number table 70 (47.0) 4 (23.5) 66 (50.0)
  Computer-generated randomisation number 39 (26.2) 11 (64.7) 28 (21.2)
  Coin tossing 2 (1.3) 1 (5.9) 1 (0.8)
  Shuffling cards or envelopes 2 (1.3) 0 (0.0) 2 (1.5)
  Drawing of lots 6 (4.1) 0 (0.0) 6 (4.5)
  Visit order 30 (20.1) 1 (5.9) 29 (22.0)
Unclear 99 (39.9) 12 (41.4) 87 (39.7)
Methods of concealment of allocation
Reported 31 (12.5) 10 (35.5) 21 (9.6)
  Central allocation (telephone, web-based) 1 (3.2) 1 (10.0) 0 (0.0)
  Sequentially numbered, opaque, sealed envelopes 30 (96.8) 9 (90.0) 21 (100.0)
Unclear 217 (87.5) 19 (65.5) 198 (90.4)
Use of block randomisation
Yes 15 (6.0) 11 (37.9) 4 (1.8)
Unclear 233 (94.0) 18 (62.1) 215 (98.2)
Use of stratification at randomisation
Yes 9 (3.6) 4 (13.8) 5 (2.3)
Unclear 239 (96.4) 25 (86.2) 214 (97.7)
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Table 3 Interventions and blinding of included trials
Items
Total
(n=248,%)
English
(n=29,%)
Chinese
(n=219,%)
Type of the acupuncture of the experimental group
  Filiform/ordinary needle 107 (43.1) 20 (69.0) 87 (39.7)
  Electro-acupuncture 98 (39.5) 4 (13.8) 94 (42.9)
  Fire needle 14 (5.7) 0 (0) 14 (6.4)
  Laser acupuncture 4 (1.6) 4 (13.8) 0 (0.0)
  Non-conventional acupuncture* 20 (8.1) 1 (3.4) 19 (86.8)
  Combination of different types of acupuncture 5 (2.0) 0 (0) 5 (2.3)
The intervention of the control group
  Multiple interventions† 64 (25.8) 2 (6.9) 62 (28.3)
  Acupuncture and moxibustion 51 (20.6) 2 (6.9) 49 (22.4)
  Pharmacological interventions 45 (18.1) 2 (6.9) 43 (19.6)
  Needle-knife 29 (11.7) 1 (3.4) 28 (12.8)
  Physical treatments 22 (8.9) 3 (10.3) 19 (8.7)
  Acupuncture 21 (8.5) 5 (17.2) 16 (7.3)
   Filiform needle 9 (42.9) 1 (3.4) 8 (3.7)
   Electro-acupuncture 8 (38.1) 1 (3.4) 7 (3.2)
   Fire needle 4 (19.0) 0 (0) 4 (1.8)
  Sham acupuncture 8 (3.2) 8 (27.6) 0 (0)
  Placebo acupuncture 5 (2.0) 5 (17.2) 0 (0)
  Moxibustion 2 (0.8) 0 (0) 2 (0.9)
  Waiting list 1 (0.4) 1 (3.4) 0 (0)
Standardisation of the procedure
  Acupuncture procedure was standardised 25 (10.1) 9 (31.0) 16 (7.3)
  Unclear 223 (89.9) 20 (69.0) 203 (92.7)
How was the acupuncture procedure standardised?
Reported 18 (7.3) 8 (27.6) 10 (4.6)
  According to written manuals or specific guidelines 11 (61.1) 2 (25.0) 9 (90.0)
  Standardised acupuncture protocol 7 (38.9) 6 (75.0) 1 (10.0)
Unclear 230 (92.7) 21 (72.4) 209 (95.4)
Reasoning for the acupuncture procedure
Reported 84 (33.9) 13 (44.8) 71 (32.4)
  Theory 60 (71.4) 7 (53.8) 53 (74.7)
  Literature 3 (3.6) 2 (15.4) 1 (1.4)
  Consensus methods 21 (25.0) 4 (30.8) 17 (23.9)
Unclear 164 (66.1) 16 (55.2) 148 (67.6)
Who undertook acupuncture procedures?
  Acupuncturist/doctor/physiotherapists 18 (7.3) 15 (51.7) 3 (1.4)
  Unclear 230 (92.7) 14 (48.3) 216 (98.6)
Blinding
Any blinding 233 (94.0) 23 (79.3) 210 (95.9)
  Patient
   Yes 16 (6.9) 14 (60.9) 2 (1.0)
   No 11 (4.7) 6 (26.12) 5 (2.4)
  Acupuncturist
Continued
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Factors associated with methodological quality indicators
The multiple regression analysis showed that no prespec-
ified factors were statistically associated with better use of 
method for generating randomisation sequence; results 
of which are summarised in table 6. However, trials 
published in English (OR 4.99, 95% CI 1.72 to 14.47) 
and conducted in multiple centres (OR 4.49, 95% CI 
1.39 to 14.53) were associated with a higher likelihood 
of achieving allocation concealment. Similarly, trials 
published in English were more likely to achieve blinding 
of participants and personnel or outcome assessors (OR 
230.74, 95% CI 19.93 to 2671.65; OR 199.82, 95% CI 22.97 
to 1738.10, respectively) after adjusting for the influence 
of funding, sample size and study centres. Multicentre 
trials were associated with a higher likelihood of achieving 
blinding of outcome assessors (OR 65.47, 95% CI 6.03 to 
710.78).
disCussiOn
Main findings
In this study, we found that the published RCTs testing 
acupuncture for KOA were at high risk of bias. The meth-
odological quality issues were, however, complicated with 
inadequate reporting of trials. We found that 66.1% of 
trials were unclear in the specification of acupuncture 
procedure, 92.7% in procedure standardisation, 39.9% in 
randomisation and 87.5% in concealment. The apparent 
lack of rigorous methods was in part due to the poor 
reporting of trials.
However, one may reasonably infer that adequate use 
of rigorous methodologies for design, conduct and anal-
yses is less likely among trials with serious limitations 
in reporting. We found that, among those trials which 
provided methodological details, many used inadequate 
methods to generate a randomisation sequence, such as 
coin tossing and alternate visit number; 12.5% of trials 
performed allocation concealment, but only one used 
central randomisation, the optimal approach to achieve 
adequate allocation concealment. In addition, very few 
trials considered block randomisation and stratifica-
tion at randomisation, the two important approaches to 
achieving prognostic balance. These two techniques are 
particularly useful for acupuncture trials, since the study 
population is often present with a variety of characteristics
Acupuncture represents a practitioner-dependent, 
complex intervention.16 Acupuncture interventions are 
subjected to a high degree of variability in terms of the 
acupuncturist’s expertise and styles.16 17 Careful consid-
eration of standardisation of acupuncture procedures 
is an important aspect in conducting high-quality trials, 
and explicit description of the acupuncture procedure is 
essential to determine whether the results are generalis-
able.18 Our study found that many types of acupuncture 
were used. However, only 10% of trials explicitly stated 
whether and how acupuncture procedures were stan-
dardised, and 7.3% of trials specified who would be qual-
ified for operating the procedures.
Another relevant issue is blinding. Our study found 
that 94% of trials reported blinding, but 88% of them 
did not specify who were blinded; only 5% of trials 
attempted to use sham procedures. Blinding appeared 
to be challenging in the setting of acupuncture trials. 
Sometimes, caregivers, who administer acupuncture 
procedures, and patients may not be blinded if inter-
ventions between treatment and control groups have 
varying features. However, trialists should always 
consider blinding of both caregivers and patients under 
all circumstances. Unfortunately, nearly no trials clearly 
justified why blinding was not implemented. In addi-
tion, others parties such as outcome assessors can always 
be masked. This is particularly relevant for trials of KOA, 
since the main outcomes are often patient centred (such 
as pain, disability, quality of life and global perceived 
effect) and subjective.19
Items
Total
(n=248,%)
English
(n=29,%)
Chinese
(n=219,%)
  Yes 0 (0.0) 0 (0.0) 0 (0.0)
  No 21 (9.0) 16 (69.6) 5 (2.4)
 Outcome assessor
  Yes 15 (6.4) 12 (52.2) 3 (1.4)
  No 5 (2.1) 5 (21.7) 0 (0.0)
 Data analyst
  Yes 10 (4.3) 7 (30.4) 3 (1.4)
  No 5 (2.1) 5 (21.7) 0 (0.0)
 Details not reported‡ 204 (87.6) 7 (30.4) 197 (93.8)
Unclear 15 (6.0) 6 (20.7) 9 (4.1)
*Non-conventional acupuncture including silver needle, Fu's subcutaneous, blade needle, longitudinal needle, ear needle and head needle.
†Multiple interventions including acupuncture or/and pharmacological or/and physical treatments in the control group.
‡Trials just stated as ‘single-blinded/double-blinded/blinded’ without giving further information.
Table 3 Continued 
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The lack of specifying primary outcomes and calcu-
lating sample sizes are two other concerning issues. Our 
study showed that only 10.9% of trials specified a primary 
outcome, much lower than previous studies (45% and 
73%),20 21 and only 6.9% clearly articulated sample size 
calculation. Such lack of explicit specification of primary 
outcomes suggested that trialists did not carefully consider 
this issue during design, despite the specification of 
primary outcome is highly relevant to the main study 
objective and subsequent sample size calculation. More-
over, there is strong evidence that significant outcomes are 
more likely to be reported.22 When the primary outcomes 
were not prespecified, the authors tended to selectively 
report outcomes based on statistical significance instead of 
the predefined clinical importance,20 thereby portraying 
an overestimation of the treatment effects. Similarly, very 
few (10 trials) determined the sample size based on the 
defined primary outcome, and included previous data 
to support sample size calculation. None of the trials 
considered interim analyses and associated stopping rule, 
even though a few trials had adopted large sample sizes 
and should have the opportunity to conduct close moni-
toring of trials through interim analysis.
Analysis of trial data has posed another issue. Our study 
found that most trials failed to adequately deal with loss 
to follow-up. Very few had prespecified how the primary 
outcome was analysed. Even more surprisingly, no trial 
explicitly considered subgroup analyses and adjustment 
for potential confounding effects. Although these condi-
tions are not always present in RCTs, particularly those 
with smaller sample sizes, their absence of consideration 
further implicates the weak planning and analysis of these 
trials.
Overall, our study revealed that the published trials 
testing acupuncture for KOA are at high risk of bias and 
identified that many methodological details are not care-
fully considered during the various stages of planning, 
design, conduct and analysis.
Table 4 Sample size calculation of included trial
Items
Total
(n=248, %)
English
(n=29, %)
Chinese
(n=219, %)
Was sample size calculation conducted?
Reported 17 (6.9) 14 (48.3) 3 (1.4)
  Yes, details of the calculation reported 17 (100.0) 14 (100.0) 3 (100.0)
  Yes, but no statistical details 0 (0.0) 0 (0.0) 0 (0.0)
  No 0 (0.0) 0 (0.0) 0 (0.0)
Unclear 231 (93.1) 15 (51.7) 216 (98.6)
Was the sample size calculated based on the defined primary outcome?
Reported 17 (100.0) 14 (100.0) 3 (100.0)
  Yes 10 (58.8) 9 (64.3) 1 (33.3)
  Unclear 7 (41.2) 5 (35.7·) 2 (66.7)
Did the trial define α?
Reported 17 (100.0) 14 (100.0) 3 (100.0)
  Yes 9 (52.9) 9 (64.3) 0 (0.0)
  Unclear 8 (47.1) 5 (35.7) 3 (100.0)
Did the trial define β?
Reported 17 (100.0) 14 (100.0) 3 (100.0)
  Yes 12 (70.6) 12 (85.7) 0 (0.0)
  Unclear 5 (29.4) 2 (14.3) 3 (100.0)
What basis was the sample size calculated?
Reported 11 (64.7) 9 (64.3) 2 (66.7)
  Pilot study 2 (18.2) 2 (22.2) 0 (0.0)
  Previous study 9 (81.8) 7 (77.8) 2 (100.0)
Unclear 6 (35.3) 5 (35.7) 1 (33.3)
Was the loss to follow-up considered?
Reported 11 (65.7) 8 (57.1) 3 (100)
  Yes 9 (81.8) 6 (75.0) 3 (100.0)
  No 2 (18.2) 2 (25.0) 0 (0.0)
Unclear 6 (35.3) 6 (42.9) 0 (0.0)
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implications for future trials
Our findings have important implications for future 
trials of acupuncture for KOA. First, one should centrally 
randomise patients based on a computer-generated 
randomisation sequence. Blocked randomisation with 
variable sizes may also improve balance of sample sizes 
between groups. In case of important prognostic factors, 
stratification should be introduced to further improve 
the balance of these factors.
All acupuncture trials of KOA should predefine primary 
outcomes in the protocol and follow the CONSORT 
guidelines (2010) to register the trial at inception. Given 
the predefined primary outcome, careful calculation of 
sample sizes should be performed with an appropriate 
alpha level and statistical power, and including important 
clinical parameters such as expected treatment effect, 
baseline risk and expected loss to follow rate. In all 
possible cases, trial investigators should justify the choices 
of the primary outcome and parameters for the sample 
size calculation.
Designing and practicing acupuncture interventions 
are important. Trial investigators should be explicit in 
their design of acupuncture procedures. In any case, 
one should consider standardising issues such as the type 
of acupuncture, acupoints and other procedural issues 
(eg, number of needle insertions/treatment sessions 
Table 5 Primary outcome and data analyses of included trials
Items
Total
(n=248,%)
English
(n=29,%)
Chinese
(n=219,%)
Specified primary outcome
  Yes 27 (10.9) 11 (37.9) 16 (7.3)
  Unclear 221 (89.1) 18 (62.1) 203 (92.7)
ITT principle used for primary outcome
Reported 27 (100.0) 11 (100.0) 16 (100.0)
  ITT analysis 7 (25.9) 5 (45.5) 2 (12.5)
  Not reported 20 (74.1) 6 (54.5) 14 (87.5)
Type of the primary outcome(s)
Reported 27 (100.0) 11 (100.0) 16 (100.0)
  Patient-reported outcome 25 (92.6) 9 (81.8) 16 (100.0)
  Laboratory results 1 (3.7) 1 (9.1) 0 (0.0)
  Patient recruitment rate 1 (3.7) 1 (9.1) 0 (0.0)
Did LTFU explicitly stated
Reported 145 (58.5) 27 (93.1) 118 (53.9)
  Yes, explicit statement: LTFU occurred 46 (31.7) 20 (74.1) 26 (22.0)
  Yes, explicit statement: LTFU did not occur 99 (68.3) 7 (25.9) 92 (78.0)
No, no explicit statement about LTFU, unclear 103 (41.5) 2 (6.9) 101 (46.1)
LTFU reported separately for the all arms
Reported 46 (100.0) 20 (100.0) 26 (100.0)
  Yes 37 (80.4) 18 (90.0) 19 (73.1)
  No 9 (19.6) 2 (10.0) 7 (26.9)
Comparison of baseline characteristic of LTFU
Reported 46 (100.0) 20 (100.0) 26 (100.0)
  Yes 1 (2.2) 1 (5.0) 0 (0.0)
  No 45 (97.8) 19 (95.0) 26 (100.0)
Analytical methods for LTFU data
Reported 6 (13.1) 6 (30.0) 0 (0.0)
  Last observation carried forward 4 (66.6) 4 (66.6) 0 (0.0)
  The worst of the scores obtained for the intervention group and 
the best obtained for the control group
1 (16.7) 1 (16.7) 0 (0.0)
  Baseline observation carried forward was used for missing data 1 (16.7) 1 (16.7) 0 (0.0)
Unclear 40 (86.9) 14 (70.0) 26 (100.0)
ITT, intention to treat; LTFU, loss to follow-up.
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and frequency and duration of treatment sessions). The 
experience of practitioners would be another factor for 
consideration, and when possible, for standardisation. 
Ideally, the qualification, training and experience of the 
acupuncturists providing the treatment should be more 
or less similar, especially for an exploratory trial.
In parallel, trial investigators should judge whether a 
blinding technique can be used according to the actual 
setting because in many situations of acupuncture trials, 
it is impractical or infeasible to blind the participants 
or study personnel. Nevertheless, blinding should be 
encouraged in an explanatory trial. They may adopt 
appropriate blinding method, such as sham acupunc-
ture, and monitor the performance of blinding regularly 
to ensure that it is well implemented.
In specifying interventions, trial investigators should 
also account for the impact of co-interventions, and 
justify their use during the course of a trial. They must 
make an effort to minimise cross-overs, so as to maintain 
interventions as planned, and develop strategies to maxi-
mise patient follow-up. In all cases, these issues should be 
documented in the study protocol.
A statistical analysis plan should be in place prior to 
undertaking data analysis. Trial investigators should 
prespecify the analytic strategies to deal with loss to 
follow-up and the missing data problem. These should 
be explicit for both primary and secondary outcomes. 
It would be highly desirable to prespecify any subgroup 
hypotheses, if relevant, and plan the corresponding 
adjusted analyses.
There are other issues that trial investigators should 
take into consideration prior to their studies, such as 
safety monitoring and specification of interim analysis 
and stopping rules.
strengths and limitations
The main strength of this study was its comprehen-
sive and systematic investigation of the methodolog-
ical details about the design, conduct and analysis of 
acupuncture RCTs for KOA. Nonetheless, several limita-
tions should be considered. The data extraction form 
was developed by our research team. Despite the use of 
trained assessors and pilot testing of the questionnaire, 
it is likely that some extracted items from the original 
article source might still incur a certain degree of misin-
terpretation which could have affected the results. The 
insufficient reporting of methodological details among 
the included trials limited our assessment of the meth-
odological quality and identification of specific meth-
odological gaps. In addition, this study did not examine 
the specification of patient population in the included 
trials, and the findings may not be applicable to other 
Table 6 Factors associated with methodological quality indicators
Items
OR and 95% CI
Crude P value Adjusted* P value*
Randomisation sequence generated
  English vs Chinese (ref) 1.39 (0.64 to 3.02) 0.41 1.09 (0.45 to 2.62) 0.85
  Multiple vs single centre (ref) 1.78 (0.66 to 4.75) 0.25 1.63 (0.57 to 4.67) 0.37
  Funding vs unclear (ref) 1.88 (1.05 to 3.37) 0.04 1.75 (0.94 to 3.26) 0.08
  Sample size>76 vs ≤76 (ref) 0.75 (0.45 to 1.23) 0.25 0.73 (0.43 to 1.22) 0.23
Allocation concealment
  English vs Chinese (ref) 4.96 (2.04 to 12.08) <0.01 4.99 (1.72 to 14.47) <0.01
  Multiple vs single centre (ref) 3.02 (0.99 to 9.17) 0.05 4.49 (1.39 to 14.53) 0.01
  Funding vs unclear (ref) 1.79 (0.80 to 3.99) 0.15 0.98 (0.36 to 2.62) 0.97
  Sample size>76 vs ≤76 (ref) 0.53 (0.24 to 1.15) 0.11 0.55 (0.24 to 1.26) 0.16
Blinding of participants and personnel
  English vs Chinese (ref) 203.47 (24.93 to 1660.49) <0.01 230.74 (19.93 to 2671.65) <0.01
  Multiple vs single centre (ref) 0.91 (0.11 to 7.35) 0.93 3.81 (0.59 to 24.46) 0.16
  Funding vs unclear (ref) 3.79 (1.31 to 10.95) 0.01 0.90 (0.22 to 3.74) 0.89
  Sample size>76 vs ≤76 (ref) 0.35 (0.10 to 1.15) 0.08 0.80 (0.16 to 3.89) 0.78
Blinding of outcome assessors
  English vs Chinese (ref) 50.82 (13.03 to 198.18) <0.01 199.82 (22.97 to 1738.10) <0.01
  Multiple vs single centre (ref) 3.63 (0.92 to 14.32) 0.07 65.47 (6.03 to 710.78) <0.01
  Funding vs unclear (ref) 2.11 (0.72 to 6.19) 0.18 0.29 (0.06 to 1.49) 0.14
  Sample size>76 vs ≤76 (ref) 0.24 (0.07 to 0.87) 0.03 0.24 (0.04 to 1.40) 0.11
*From separate logistic regression models adjusting for other factors.
ref, reference category.
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acupuncture trials. Lastly, this study did not investigate 
methodological characteristics of trials published in 
languages other than Chinese and English, which were 
expected to be scarce in the literature.
COnCLusiOn
The overall risk of bias was high among published 
RCTs testing acupuncture for KOA. When examining 
methodological details, important issues were present 
in every aspect of design, conduct and analyses. These 
included, but were not limited to, randomisation, stan-
dardisation and operation of procedures, blinding, 
outcome specification and assessment, sample size 
calculation, setting up early stopping rules and data 
analysis (such as dealing with loss to follow-up, subgroup 
and adjusted analyses). Identifying and understanding 
these important methodological gaps have profound 
implications for future trials. Our findings support 
the development of an evidence-based methodological 
guidance for the design, conduct and analysis of future 
trials testing acupuncture for KOA.
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